Establishment Labs Holdings (ESTA) Revenue (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.34% |
| Dec 31, 2025 | 20.15% |
| Sep 30, 2025 | 4.84% |
| Jun 30, 2025 | 23.98% |
| Mar 31, 2025 | -7.05% |
| Dec 31, 2024 | 10.66% |
| Sep 30, 2024 | -8.82% |
| Jun 30, 2024 | 18.70% |
| Mar 31, 2024 | 17.77% |
| Dec 31, 2023 | -18.04% |
| Sep 30, 2023 | -20.71% |
| Jun 30, 2023 | 4.38% |
| Mar 31, 2023 | 6.19% |
| Dec 31, 2022 | 14.56% |
| Sep 30, 2022 | -7.15% |
| Jun 30, 2022 | 7.12% |
| Mar 31, 2022 | 8.89% |
| Dec 31, 2021 | 21.61% |
| Sep 30, 2021 | -9.24% |
| Jun 30, 2021 | 5.47% |
| Mar 31, 2021 | 12.51% |
| Dec 31, 2020 | 18.48% |
| Sep 30, 2020 | 117.28% |
| Jun 30, 2020 | -57.22% |
| Mar 31, 2020 | 0.96% |
| Dec 31, 2019 | 6.10% |
| Sep 30, 2019 | 5.40% |
| Jun 30, 2019 | 4.36% |
| Mar 31, 2019 | 26.72% |
| Dec 31, 2018 | 0.68% |
| Sep 30, 2018 | 18.80% |
| Jun 30, 2018 | -7.47% |
| Mar 31, 2018 | 25.44% |
| Dec 31, 2017 | 61.26% |
| Sep 30, 2017 | -15.10% |